Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.
Sutekast 12.5
Sunitinib Malate Capsules 12.5 mg
Thank you for your enquiry. We will get back to you shortly!
Categories: Oncology, Oncology - Orals
Tags: kidney cancer medicines, kidney cancer treatment, Sunitinib Malate Capsules, Sutekast
Description
Description
COMPOSITION : Each Hard Gelatin Capsules
contains: Sunitinib Malate 12.5mg/25mg/50mg
SUTEKAST is indicated for treatment of
Gastrointestinal Stromal Tumor (GIST) after
disease progression on or intolerance to imatinib
mesylate.
Sutekast is indicated for the treamtment of
pancreatic cancer known as pancreatic neuroendocrine
tumors (PNETs) that has progressed and cannot be treated
with surgery or metastatic disease
SUTEKAST is also indicated for the treatment of
aadvanced kidney carcinoma.
PACKING: 28 Capsules / Bottle
Download Product PDF Attachment